Sign up to access all valuation multiples
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, as well as treatment effect evaluation, to post-discharge management and chronic disease management. It has independently developed AI technologies that underpin its products and solutions. Smart Healthcare, Smart Hospital, Intelligent Hardware, Smart Medical Insurance, and Smart Imaging Union. The Company’s revenue was mainly derived from PHC services and patient services.
2021
911
LTM Revenue $137M
LTM EBITDA -$6.3M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
iFLYHealth has a last 12-month revenue (LTM) of $137M and a last 12-month EBITDA of -$6.3M.
In the most recent fiscal year, iFLYHealth achieved revenue of $93.9M and an EBITDA of -$15.1M.
iFLYHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See iFLYHealth valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $137M | XXX | $93.9M | XXX | XXX | XXX |
| Gross Profit | $74.4M | XXX | $51.7M | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | -$6.3M | XXX | -$15.1M | XXX | XXX | XXX |
| EBITDA Margin | -5% | XXX | -16% | XXX | XXX | XXX |
| EBIT | -$23.6M | XXX | -$15.5M | XXX | XXX | XXX |
| EBIT Margin | -17% | XXX | -16% | XXX | XXX | XXX |
| Net Profit | -$14.7M | XXX | -$17.0M | XXX | XXX | XXX |
| Net Margin | -11% | XXX | -18% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 29, 2025, iFLYHealth's stock price is HKD 108 (or $14).
iFLYHealth has current market cap of HKD 13.1B (or $1.7B), and EV of HKD 12.8B (or $1.6B).
See iFLYHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.7B | XXX | XXX | XXX | XXX | $-0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 29, 2025, iFLYHealth has market cap of $1.7B and EV of $1.6B.
iFLYHealth's trades at 17.5x EV/Revenue multiple, and -108.7x EV/EBITDA.
Equity research analysts estimate iFLYHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
iFLYHealth has a P/E ratio of -123.6x.
See valuation multiples for iFLYHealth and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 13.1x | XXX | 17.5x | XXX | XXX | XXX |
| EV/EBITDA | -285.5x | XXX | -108.7x | XXX | XXX | XXX |
| EV/EBIT | -75.6x | XXX | -106.1x | XXX | XXX | XXX |
| EV/Gross Profit | 24.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -123.6x | XXX | -98.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -76.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialiFLYHealth's last 12 month revenue growth is 34%
iFLYHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
iFLYHealth's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
iFLYHealth's rule of X is 80% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for iFLYHealth and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 34% | XXX | 40% | XXX | XXX | XXX |
| EBITDA Margin | -5% | XXX | -16% | XXX | XXX | XXX |
| EBITDA Growth | -212% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 8% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 80% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 37% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 72% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Mach7 Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
iFLYHealth acquired XXX companies to date.
Last acquisition by iFLYHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . iFLYHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was iFLYHealth founded? | iFLYHealth was founded in 2021. |
| Where is iFLYHealth headquartered? | iFLYHealth is headquartered in Hong Kong. |
| How many employees does iFLYHealth have? | As of today, iFLYHealth has 911 employees. |
| Is iFLYHealth publicy listed? | Yes, iFLYHealth is a public company listed on HKG. |
| What is the stock symbol of iFLYHealth? | iFLYHealth trades under 02506 ticker. |
| When did iFLYHealth go public? | iFLYHealth went public in 2024. |
| Who are competitors of iFLYHealth? | Similar companies to iFLYHealth include e.g. Alcidion Group, CurveBeam AI, Doctor Care Anywhere, Echo IQ. |
| What is the current market cap of iFLYHealth? | iFLYHealth's current market cap is $1.7B |
| What is the current revenue of iFLYHealth? | iFLYHealth's last 12 months revenue is $137M. |
| What is the current revenue growth of iFLYHealth? | iFLYHealth revenue growth (NTM/LTM) is 34%. |
| What is the current EV/Revenue multiple of iFLYHealth? | Current revenue multiple of iFLYHealth is 13.1x. |
| Is iFLYHealth profitable? | Yes, iFLYHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of iFLYHealth? | iFLYHealth's last 12 months EBITDA is -$6.3M. |
| What is iFLYHealth's EBITDA margin? | iFLYHealth's last 12 months EBITDA margin is -5%. |
| What is the current EV/EBITDA multiple of iFLYHealth? | Current EBITDA multiple of iFLYHealth is -285.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
